THERAPY DOSSIER · th-1801c6c8389a

Compound of white peony root oral liquid (cWPROL)

Nutraceutical

Evidence & regulatory context

Mechanism: Not recorded
Target: Not recorded
Injury models: Radiation
Reported indication: Not recorded
First approval: Not recorded
Development stage: Not recorded
ChEMBL record: Not recorded
ChEMBL max phase: Not recorded
Synonyms: Not recorded
Note: Not recorded

Clinical trials 1

0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.

NCT01852331 ↗PHASE2completed

Peony-Glycyrrhiza Decoction as Adjunctive Therapy for Antipsychotic-induced Hyperprolactinaemia in Schizophrenia

Schizophrenia · Hyperprolactinemia

Enrolment: 103 · Results not recorded

Preclinical evidence 1

1 studies reported at therapy level; 1 evidence entries itemised.

PMID 23588387 ↗2013Reported benefit

Pain-relieving effect of a compound isolated from white peony root oral liquid on acute radiation-induced esophagitis.

RatRadiationWistarMaleOralAfter induction of radiation oesophagitis

Model: X-ray irradiation producing acute radiation-induced oesophagitis

cWPROL relieved pain-related behaviour in radiation oesophagitis and decreased substance P expression, suggesting a substance P mediated mechanism.

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.

Loading the evidence…